External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Respiratory ATS 2024
Roche and Genentech at

ATS 2024

May 17 - May 22
San Diego, USA / Virtual (Hybrid)
ats.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
May 21 / Roche and Genentech
Zinpentraxin Alfa in Patients With Idiopathic Pulmonary Fibrosis (IPF): Results and Learnings From the Phase III STARSCAPE Trial
This poster reports the findings and learning from the Phase III STARSCAPE trial of zinpentraxin alfa in IPF.
Respiratory Pulmonary Fibrosis ATS-2024

Sign up or login to unlock the full suite of MEDICALLY features
May 21 / Roche and Genentech
Safety Profile of Astegolimab, An Anti-ST2 Antibody: A Systematic Review
This poster reports a systematic review of safety data from completed clinical trials of astegolimab.
Respiratory Chronic Obstructive Pulmonary Disease ATS-2024

Sign up or login to unlock the full suite of MEDICALLY features
May 19 / Roche and Genentech
Zinpentraxin Alfa in Patients With Idiopathic Pulmonary Fibrosis: Results and Learnings From the Phase III STARSCAPE Trial
This oral presentation reports the findings and learning from the Phase III STARSCAPE trial of zinpentraxin alfa in IPF.
Respiratory Pulmonary Fibrosis ATS-2024
06:30 PM
Duration 2hrs San Diego, USA
Safety Profile of Astegolimab, An Anti-ST2 Antibody: A Systematic Review
Kelsen S, Alvaro G, Millette L, Mohan D, Yang X, Brightling CE
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:15 PM
Duration 2hrs San Diego, USA
Zinpentraxin Alfa in Patients With Idiopathic Pulmonary Fibrosis (IPF): Results and Learnings From the Phase III STARSCAPE Trial
Richeldi L, Schiffman C, Behr J, Inoue Y, Corte TJ, Cottin V, Jenkins G, Nathan SD, Raghu G, Walsh SLF, Jayia P, Kamath N, Martinez FJ
Respiratory | Pulmonary Fibrosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr United States
Zinpentraxin Alfa in Patients With Idiopathic Pulmonary Fibrosis: Results and Learnings From the Phase III STARSCAPE Trial
Richeldi L, Schiffman C, Behr J, Inoue Y, Corte TJ, Cottin V, Jenkins G, Nathan SD, Raghu G, Walsh SLF, Jayia P, Kamath N, Martinez FJ
Respiratory | Pulmonary Fibrosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.